- Recce Pharmaceuticals (RCE) has lodged an application to commence human clinical trials for its topical burns treatment, RECCE 327
- The ASX-lister announced it had registered for the trial with the Australian and New Zealand Clinical Trial Registry for a phase I/II topical burns study
- The study is set to test 30 patients over two weeks in a bid to test the efficacy of the drug
- In a broader context, Recce said the application represents one of the final administration stages required before the trial can commence
Read the full article on the Market Herald here
- Forums
- ASX - By Stock
- RCE
- Recce Pharmaceuticals makes first steps towards new trials
Recce Pharmaceuticals makes first steps towards new trials
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.0¢ |
Change
0.010(2.33%) |
Mkt cap ! $89.62M |
Open | High | Low | Value | Volume |
43.0¢ | 44.0¢ | 43.0¢ | $24.01K | 55.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 72121 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 29087 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 72121 | 0.430 |
3 | 77224 | 0.425 |
2 | 150903 | 0.420 |
3 | 127049 | 0.415 |
7 | 153894 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 29087 | 2 |
0.460 | 12868 | 1 |
0.465 | 23931 | 1 |
0.470 | 10000 | 1 |
0.495 | 2020 | 1 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
44.0¢ |
  |
Change
0.010 ( 2.33 %) |
|||
Open | High | Low | Volume | ||
43.5¢ | 44.0¢ | 43.0¢ | 7544 | ||
Last updated 15.59pm 29/03/2024 ? |
Featured News
RCE (ASX) Chart |